FLT3 and acute myeloid leukemia: To determine whether FLT3-ITD activated downstream molecules before reaching the PM, we treated AML cells with BFA, M-COPA (blockers of ER export to the Golgi24–26,37), or monensin (an inhibitor of secretory trafficking thorough blocking Golgi export21,22,33,38,39).